1Spatial (SPA LN) £3m contract win with a global healthcare provider | blur Group (BLUR LN) Revenue in line; EBITDA and cash better | Brewin Dolphin Holdings (BRW LN) +3.8% Q1 FuM growth, record discretionary gross inflows | Cello Group (CLL LN) On-track | Creston (CRE LN) Revenue impacted + costs not flexible enough = Downgrades | Euromoney Institutional Investor (ERM LN) Move to SELL ahead of trading update (28 January) | Futura Medical (FUM LN) Capital Markets Day highlights development and c ....
27 Jan 2016
Morning Song
Maistro (MAIS:LON), 0 | Cello Health (CLL:LON), 0 | Futura Medical plc (FUM:LON), 33.4 | 1Spatial Plc (SPA:LON), 63.5 | Conduit Holdings Ltd. (CRE:LON), 0
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Song
Maistro (MAIS:LON), 0 | Cello Health (CLL:LON), 0 | Futura Medical plc (FUM:LON), 33.4 | 1Spatial Plc (SPA:LON), 63.5 | Conduit Holdings Ltd. (CRE:LON), 0
- Published:
27 Jan 2016 -
Author:
N+1 Singer Team -
Pages:
16
1Spatial (SPA LN) £3m contract win with a global healthcare provider | blur Group (BLUR LN) Revenue in line; EBITDA and cash better | Brewin Dolphin Holdings (BRW LN) +3.8% Q1 FuM growth, record discretionary gross inflows | Cello Group (CLL LN) On-track | Creston (CRE LN) Revenue impacted + costs not flexible enough = Downgrades | Euromoney Institutional Investor (ERM LN) Move to SELL ahead of trading update (28 January) | Futura Medical (FUM LN) Capital Markets Day highlights development and c ....